Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister and Chairman of the Board of Directors of the Riyadh Biotechnology Center Foundation, the Saudi capital is preparing to host the fourth edition of the "Riyadh Global Biotechnology Summit for Medicine" during the period from September 14 to 16, 2026. This global event is organized by the Health Affairs of the Ministry of National Guard, represented by the King Abdullah International Medical Research Center (KAIMRC), in strategic partnership with the Ministry of Investment.
Enhancing the Kingdom's position as a global hub for biotechnology
This summit holds significant strategic importance in light of the ambitious national vision spearheaded by His Royal Highness Crown Prince Mohammed bin Salman, which aims to position the Kingdom of Saudi Arabia as a leading global hub for biotechnology. The summit is a direct outcome of the launch of the National Biotechnology Strategy, which focuses on addressing national and regional health challenges, enhancing pharmaceutical security, and localizing advanced biotechnology industries. Through these events, the Kingdom seeks to build an integrated system that combines scientific research, technological development, and pharmaceutical manufacturing, thereby strengthening its competitiveness on the international stage in this vital sector.
An international platform for innovation and investment
The Riyadh Global Biotechnology Summit is one of the leading international platforms that brings together a select group of global minds and leaders. The fourth edition is expected to witness a wide attendance of government officials, decision-makers, CEOs of major global pharmaceutical companies, as well as scientists, experts, and specialized investors. The summit sessions will focus on discussing the latest trends in medical biotechnology, including cell and gene technologies and the applications of artificial intelligence in life sciences, opening up broad prospects for strategic partnerships and attracting high-quality investments that support the national economy.
Supporting leadership and empowering the health sector
In his remarks on this occasion, His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of the National Guard and a member of the Board of Directors of the Riyadh Biotechnology Center Foundation, expressed his deepest gratitude to His Royal Highness the Crown Prince for his generous patronage of the summit. His Highness affirmed that this patronage embodies the unwavering support that the wise leadership provides to the promising biotechnology sector, and its continuous commitment to empowering efforts aimed at achieving the objectives of the national strategy, which will positively impact the quality of life and healthcare services provided.
Economic and developmental dimensions within Vision 2030
The organization of this summit is fully aligned with the objectives of the Kingdom's Vision 2030, which seeks to diversify national income sources and build a knowledge-based and innovation-driven economy. The biotechnology sector is a key pillar in developing this "bioeconomy," contributing to the creation of high-quality jobs, attracting foreign investment, and localizing knowledge. The summit also highlights the Kingdom's pivotal role in leading global public health initiatives and supporting biomedical research that offers innovative solutions to intractable diseases, thus solidifying Saudi Arabia's position as a leading force in shaping the future of healthcare globally.
